Merck, Wellcome Trust Looking at New Rotavirus Vaccine for Poor

A joint venture between U.S. drugmaker Merck and Britain’s Wellcome Trust charity said on Monday it is working on an oral rotavirus vaccine designed to be cheaper and easier to use than current shots.
XE